Back

In-hospital beta-blocker initiation is associated with improved survival in AF-HFpEF with tachycardia

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Contemporary beta‑blocker pharmacotherapy Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sumino Naito

(Japan)

7 More presentations in this session

Presentation thumbnail
Metoprolol versus bisoprolol in patients with acute myocardial infarction: a target trial emulation study
Doctor T. Yang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
β-blocker adherence trajectories and 5-year clinical outcomes in PCI-treated ACS patients with LVEF ≥50%: a group-based trajectory modeling analysis
Professor M. Qiu (Shenyang, CN)
Abstract Slides Video
Presentation thumbnail
Beta-blocker therapy after myocardial infarction in the PCI Era: an updated meta-analysis
Doctor J. Aleman (Cebu City, PH)
Abstract Slides Video
Presentation thumbnail
The range of left ventricular ejection fraction associated with survival benefit from beta-blockers
Professor J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blockers after myocardial infarction in patients with preserved or mildly reduced left ventricular ejection fraction: a meta-analysis of randomised trials
Mr L. Neira Chunga (Yurimaguas, PE)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary beta‑blocker pharmacotherapy

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of beta-blocker discontinuation and initiation in acute heart failure
29 June 2021
thumbnail
Congress Presentation
Resting heart rate and cardiovascular outcomes in patients with atrial fibrillation: CODE-AF registry
4 April 2022
thumbnail
Congress Presentation
The role of drug therapy in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction
31 August 2024
thumbnail
Congress Presentation
Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources